References
- Shin HR, Oh JK, Masuyer E, Curado MP, Bouvard V, Fang YY, et al. Epidemiology of cholangiocarcinoma: an update focusing on risk factors. Cancer Sci 2010; 101: 579-85. doi: 10.1111/j.1349-7006.2009.01458.x
- Zhou Y, Zhou G, Gao X, Xu C, Wang X, Xu P. Apparent diffusion coefficient value of mass-forming intrahepatic cholangiocarcinoma: a potential imaging biomarker for prediction of lymph node metastasis. Abdom Radiol 2020; 45: 3109-18. doi: 10.1007/s00261-020-02458-x.
- Lim JH. Cholangiocarcinoma: morphologic classification according to growth pattern and imaging findings. AJR Am J Roentgenol 2003; 181: 819-27. doi: 10.2214/ajr.181.3.1810819
- Mungai F, Morone M, Villanacci A, Bondioni MP, Mazzoni LN, Grazioli L, et al. Diffusion weighted MR and apparent diffusion coefficient measurement in classification and characterization of noncystic focal liver lesions: does a clinical role exist? Medicine (Baltimore) 2014; 93: e40. doi: 10.1097/MD.0000000000000040
- Shenoy-Bhangle A, Baliyan V, Kordbacheh H, Guimaraes AR, Kambadakone A. Diffusion weighted magnetic resonance imaging of liver: Principles, clinical applications and recent updates. World J Hepatol 2017; 9: 1081-91. doi: 10.4254/wjh.v9.i26.1081
- Namimoto T, Nakagawa M, Kizaki Y, Itatani R, Kidoh M, Utsunomiya D, et al. Characterization of liver tumors by diffusion-weighted imaging: Comparison of diagnostic performance using the mean and minimum apparent diffusion coefficient. J Comput Assist Tomogr 2015; 39: 453-61. doi: 10.1097/RCT.0000000000000228
- Rawla P, Barsouk A. Epidemiology of gastric cancer: global trends, risk factors and prevention. Prz Gastroenterol 2019; 14: 26-38. doi: 10.5114/pg.2018.80001
- Zheng DX, Ning AY, Levoska MA, Xiang L, Wong C, Scott JF, et al. Predicting liver metastasis of gastrointestinal tract cancer by diffusion-weighted imaging of apparent diffusion coefficient values. World J Gastroenterol 2016; 22: 3031-7. doi: 10.3748/wjg.v22.i10.3031
- Wang K, Zhang H, Xia Y, Liu J, Shen F. Surgical options for intrahepatic cholangiocarcinoma. Hepatobiliary Surg Nutr 2017; 6: 79-90. doi: 10.21037/hbsn.2017.01.06
- Vanderveen KA, Hussain HK. Magnetic resonance imaging of cholangiocarcinoma. Cancer Imaging 2004; 4: 104-15. doi: 10.1102/1470-7330.2004.0018
- Maetani Y, Itoh K, Watanabe C, Shibata T, Ametani F, Yamabe H, et al. MR imaging of intrahepatic cholangiocarcinoma with pathologic correlation. AJR Am J Roentgenol 2001; 176: 1499-507. doi: 10.2214/ajr.176.6.1761499
- Kele PG, van der Jagt EJ. Diffusion weighted imaging in the liver. World J Gastroenterol 2010; 16: 1567-76. doi: 10.3748/wjg.v16.i13.1567
- Drevelegas K, Nikiforaki K, Constantinides M, Papanikolaou N, Papalavrentios L, Stoikou I, et al. Apparent diffusion coefficient quantification in determining the histological diagnosis of malignant liver lesions. J Cancer 2016; 7: 730-5. doi: 10.7150/jca.14197
- Lee J, Kim SH, Kang TW, Song KD, Choi D, Jang KT. Mass-forming intrahepatic cholangiocarcinoma: diffusion-weighted imaging as a preoperative prognostic marker. Radiology 2016; 281: 119-28. doi: 10.1148/radiol.2016151781
- Yamada S, Morine Y, Imura S, Ikemoto T, Arakawa Y, Saito Y, et al. Prognostic prediction of apparent diffusion coefficient obtained by diffusion-weighted MRI in mass-forming intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Sci 2020; 27: 388-95. doi: 10.1002/jhbp.732
- Kovač JD, Galun D, Đurić-Stefanović A, Lilić G, Vasin D, Lazić L, et al. Intrahepatic mass-forming cholangiocarcinoma and solitary hypovascular liver metastases: is the differential diagnosis using diffusion-weighted MRI possible? Acta Radiol 2017; 58: 1417-26. doi: 10.1177/0284185117695666